AWM
FLNA

Avior Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Avior Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8
Closed -$162 – 3451
2024
Q1 		$162 Buy
+8
New +$184 ﹤0.01% 2968
2022
Q2 		– Sell
-731
Closed -$27K – 1206
2022
Q1 		$27K Hold
731
– – ﹤0.01% 672
2021
Q4 		$31K Buy
+731
New +$38.3K ﹤0.01% 639

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Avior Wealth Management's FLNA Position: Q2 2024 in Review

Avior Wealth Management sold out of Filana Therapeutics (FLNA) in Q2 2024, closing a stake of 8 shares — an estimated $162 sold.

Avior Wealth Management first reported a position in FLNA in Q4 2021 and held it in 3 quarters. The position peaked at $31K in Q4 2021. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

  • Avior Wealth Management reported no remaining Filana Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 8 Filana Therapeutics shares in Q2 2024, an estimated $162.
  • Avior Wealth Management first reported a position in Filana Therapeutics in Q4 2021 and held it in 3 quarters.
  • Avior Wealth Management's Filana Therapeutics position peaked at $31K in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.